Novo Nordisk
Ozempic Drug Semaglutide Could Protect Kidneys, Study Finds
Health
Topline Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could also help ...
3 Monster Stocks in the Making You Can Buy Right Now
Business
If you go to California’s Redwood National Park, you can see the world’s tallest tree — a redwood called Hyperion that’s over ...
Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
Sports
Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript May 2, 2024 Novo Nordisk A/S misses on earnings expectations. Reported EPS is ...
Forget Nvidia, These Unstoppable Stocks Are Better Buys
Business
Nvidia has been an amazing stock to own over the past few years, generating incredible returns for investors. But the risk is ...
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
Business
Eli Lilly and Novo Nordisk have been among the hottest healthcare stocks to own over the past few years. Since 2021, shares ...
Weight-loss drugs tied to benefit after hip replacement for patients
Health
(Reuters) — New diabetes and weight-loss drugs may benefit patients undergoing hip replacement, without adding to complication risks, according to preliminary data ...
Novo Nordisk sees double-digit FY growth as Q4 profit beats estimate
Business
(Correcting to show forecasts for sales, profit growth in paragraph 1 are not for new record) COPENHAGEN/LONDON (Reuters) -Novo Nordisk on Wednesday ...
FDA investigates reports of hair loss, suicidal thoughts in people using popular diabetes, weight loss drugs
Health
The Food and Drug Administration (FDA) is looking into reports of adverse side effects from using diabetes medications such as Ozempic and ...
Who, and what, are they good for?
Science
By Michele Gershberg (Reuters) – Powerful weight-loss medicines like Novo Nordisk’s Wegovy leapt into public view in 2023, from social media to ...
Eli Lilly stock could soar 140% by 2028 as more people use weight-loss drugs, Goldman says
Business
Sandy Huffaker for The Washington Post via Getty Images Eli Lilly stock could soar 140% by 2028 as millions of Americans begin ...